Maccura Biotechnology Co.Ltd (300463.SZ)

13.68 +0.54 (+4.11%) At close: 03:04PM CST

Maccura Biotechnology Co.Ltd

Hi-tech Zone
No. 8, Anhe 2nd Road
Chengdu 611730
China
86 28 8173 1888
https://www.maccura.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 3,362

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Wu Mingjian	GM & Director	N/A	N/A	1977
Ms. Shan Yin	CFO & Director	N/A	N/A	1981
Ms. Ping Yu	Administrative Director & Manager of Human Resource Department	N/A	N/A	1981
Mr. Shengguo Xu	Director of Marketing & Director	N/A	N/A	1979
Ms. Wei Shi	Secretary & Director of Strategic Investment	N/A	N/A	1975
Ms. Hui Yang	Director of Production - Reagents	N/A	N/A	1968

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. Maccura Biotechnology Co.Ltd was incorporated in 1994 and is based in Chengdu, China.

Corporate governance

Maccura Biotechnology Co.Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.